Medtronic touts one-year data from insulin pump study

Medtronic touts one-year data from insulin pump study

Source: 
Drug Delivery Business News
snippet: 

Medtronic (NYSE:MDT) and UnitedHealthcare (NYSE:UNH) today touted first-year results from a 6,000-person analysis designed to compare hospital admission rates between people with diabetes using insulin pumps and people controlling their diabetes with multiple daily injections of insulin.